CTRI/2024/12/078566尚未招募不适用
Comparative evaluation of anti-oxidative and anti-inflammatory biomarkers level on treatment with Prednisolone, Mesalazine and Azathioprine in different groups of IBD patients
DEPARTMENT OF HEALTH RESEARCH1 个研究点 分布在 1 个国家目标入组 96 人开始时间: 2025年1月1日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 96
- 试验地点
- 1
- 主要终点
- This is the first study which will emphasis over the biomarkers status at antioxidative and anti-inflammatory level which is required in the present time to develop a long term effective therapy for IBD patients
研究概览
简要总结
This Randomized controlled trial has withdrawn due to non-availability of patients at the site (no patient is recruited) and withdrawal was approved by the funding agency and informed to the Institutional Ethics Committee, kindly withdraw the study from CTRI also
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients of 18-60 yrs age group
- •Patients willing to provide written informed consent
- •Patients diagnosed with IBD.
排除标准
- •Patients with smoking, or alcohol addiction during the last 3 months
- •Patients who are not willing to provide written informed consent
- •Pregnant and lactating women
- •Patients with history of allergy to the study drugs.
结局指标
主要结局
This is the first study which will emphasis over the biomarkers status at antioxidative and anti-inflammatory level which is required in the present time to develop a long term effective therapy for IBD patients
时间窗: at baseline and after one month of treatment
次要结局
- a long term effective therapy along with no or little side effects for the better lifestyle of IBD patients(1 At baseline)
研究者
Dr Savita Devi
Kalpana Chawla Govt. Medical College Karnal
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
Evaluation and Comparison of 12Hour Moisturization Efficacy and Safety of a Skincare FormulationCTRI/2025/01/079508Panacea Biotec Pharma Ltd.33
尚未招募
1 期
Exploratory Clinical Study on the Safety and Efficacy of CD19X CAR-T Cell Injection in the Treatment of Relapsed/Refractory Large B-Cell LymphomaNCT07447726Institute of Hematology & Blood Diseases Hospital, China3
尚未招募
2 期
Targeting inflammation to reduce 90-day and 1-year postoperative severe morbidity in patients with unfavorable inflammatory profile undergoing oncologic surgery (POST CARE Trial)2024-515333-14-03Fondazione IRCCS Istituto Nazionale Dei Tumori83
尚未招募
Unknown
Anti-ageing and anti-inflammatory activity of Miror Revive tabletsCTRI/2025/09/095362Miror Therapeutics Pvt Ltd40
招募中
4 期
LOW DOse vs standard dose and administration TIme in near-infrared fluorescence cholangiography during laparoscopic cholecystectomy: a randomised clinical trial.2025-522535-33-00Fundacion Instituto De Estudios De Ciencias De La Salud De Castilla Y Leon122